Researchers from Tokyo Medical and Dental University (TMDU), Takeda Pharmaceutical Co., Ltd. and Ionis Pharmaceuticals, USA, show that heteroduplex oligonucleotide drugs conjugated with cholesterol ...
Antisense oligonucleotides (ASOs) have been shown to effectively rescue defects in preclinical Timothy syndrome models, a neurodevelopmental disorder associated with significant morbidity and ...
A proof-of-concept study carried out at UCL Institute of Ophthalmology with funding from Fight for Sight has highlighted the potential of a targeted antisense oligonucleotide (ASO) therapy to treat ...
A promising therapy for a range of brain diseases involves antisense oligonucleotides (ASOs) - specialized molecules that can modulate RNA and alter protein production - directly injected into the ...
Definition: Antisense therapy is a treatment strategy that uses short, synthetic, single-stranded nucleic acids – called antisense oligonucleotides (ASOs) – to bind to a complementary RNA sequence ...
The MarketWatch News Department was not involved in the creation of this content. Research, published in Nucleic Acids Research, identifies splice-modulating ASO that corrects the effects of a ...
PHILADELPHIA--(BUSINESS WIRE)--AUM LifeTech, Inc., a Philadelphia-based biotech company, has partnered with the Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results